Outrage over escalating prices for Mylan’s EpiPen forced the company to react Thursday, as lawmakers demanded relief for parents with children susceptible to severe allergic reactions to food or to bee stings who found themselves forced to add the $608 drug device to their lists of back-to-school supplies.